Granite Point Capital Management, L.P. Rocket Pharmaceuticals, Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$15.5 - $22.76 $310,000 - $455,200	20,000 Added 16.67%	140,000 $2.74 Million
Q3 2022 Nov 04, 2022	BUY	$12.37 - $18.41 $494,799 - $736,400	40,000 Added 50.0%	120,000 $1.92 Million
Q2 2022 Aug 05, 2022	BUY	$7.96 - $16.64 $636,800 - $1.33 Million	80,000 New	80,000 $1.1 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.01B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.